Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Three novel series of vanilloid VR1 antagonists presented by GSK

Nov. 2, 2004

Gruenenthal describes new NOS inhibitors with analgesic activity

Oct. 29, 2004

New GSK-3beta inhibitors and their use in Alzheimer's disease and other disorders

Oct. 29, 2004

New alpha2delta-selective calcium channel ligands discovered at Pfizer

Oct. 29, 2004

Encysive scientists design new urotensin II antagonists

Oct. 29, 2004

New antirotavirus agents prepared and tested at ViroPharma

Oct. 29, 2004

Guilford researchers present novel NAALADase inhibitors

Oct. 29, 2004

Novel antibacterial methionyl tRNA synthetase inhibitors claimed by Replidyne

Oct. 29, 2004

Vertex describes Na+ and/or Ca2+ channel blockers for pain and other uses

Oct. 28, 2004

New ALK5 inhibitors covered by Pfizer patent

Oct. 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...